Gaspar Bobby 4

4 · Orchard Therapeutics plc · Filed Oct 6, 2022

Form 4

Period: 2022-10-04

DirectorSee Remarks

Transactions

Award
Stock Option (Right to Buy)
2022-10-04+200,000→ 200,000 total
Exercise: $0.58Exp: 2030-01-01→ Ordinary Shares (200,000 underlying)
Award
Stock Option (Right to Buy)
2022-10-04+300,000→ 300,000 total
Exercise: $0.58Exp: 2030-03-31→ Ordinary Shares (300,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2022-10-04−850,000→ 0 total
Exercise: $5.98Exp: 2031-01-31→ Ordinary Shares (850,000 underlying)
Award
Stock Option (Right to Buy)
2022-10-04+850,000→ 850,000 total
Exercise: $0.58Exp: 2031-01-31→ Ordinary Shares (850,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2022-10-04−55,006→ 0 total
Exercise: $5.98Exp: 2031-01-31→ Ordinary Shares (55,006 underlying)
Award
Stock Option (Right to Buy)
2022-10-04+55,006→ 55,006 total
Exercise: $0.58Exp: 2031-01-31→ Ordinary Shares (55,006 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2022-10-04−50,000→ 0 total
Exercise: $12.54Exp: 2029-01-15→ Ordinary Shares (50,000 underlying)
Award
Stock Option (Right to Buy)
2022-10-04+50,000→ 50,000 total
Exercise: $0.58Exp: 2029-01-15→ Ordinary Shares (50,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2022-10-04−200,000→ 0 total
Exercise: $13.58Exp: 2030-01-01→ Ordinary Shares (200,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2022-10-04−300,000→ 0 total
Exercise: $7.05Exp: 2030-03-31→ Ordinary Shares (300,000 underlying)

Footnotes (7)

[F1]On October 4, 2022, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.
[F2]The shares subject to this option vest in equal monthly installments over the four years after January 16, 2019.
[F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
[F4]The shares subject to this option vest in equal monthly installments over the four years after January 2, 2020.
[F5]The shares subject to this option vest in equal monthly installments over the four years after April 1, 2020.
[F6]The shares subject to this option vest in equal monthly installments over the four years after February 1, 2021.
[F7]The shares subject to this option are fully vested as of the date hereof.

Documents

1 file